We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 21-40 of 10,000 results
  1. Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe

    Purpose

    Fentanyl, a highly potent synthetic opioid used in cancer and non-cancer pain, is approved for various routes of administration. In Europe,...

    Kathrin Jobski, Carsten Bantel, Falk Hoffmann in European Journal of Clinical Pharmacology
    Article Open access 16 December 2022
  2. Effects of Current Psychotropic Drugs on Inflammation and Immune System

    The immune system and inflammation are involved in the pathological progression of various psychiatric disorders such as depression or major...
    Shvetank Bhatt, Arghya Kusum Dhar, ... Ashish Suttee in Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders
    Chapter 2023
  3. Nicotine Pharmacology, Abuse, and Addiction

    Despite increased public awareness of the substantial health risks, tobacco use remains one of the greatest public health concerns around the world....
    Megan B. Miller, Marina R. Picciotto in Neuroscience in the 21st Century
    Reference work entry 2022
  4. Side Effects of Central Analgesic Drugs

    Strong opioid analgesics, such as morphine, are the most widely used, centrally acting class of analgesics that are available in the clinic for the...
    Living reference work entry 2022
  5. Saliva and Drugs of Abuse

    The drug overdose epidemic resulted in approximately 630,000 deaths from 1999 to 2016 according to the Center for Disease Control and Prevention...
    Mahvash Navazesh, Azadeh Ahmadieh in Salivary Bioscience
    Chapter 2020
  6. Environmental Enrichment and the Effects on Drug Abuse Vulnerability: The Last Ten Years

    Environmental enrichment in rats during development has been shown to reliably alter the sensitivity to various drugs of abuse. The current chapter...
    Dustin J. Stairs, Taena Hanson, Kendall Kellerman in Methods for Preclinical Research in Addiction
    Protocol 2022
  7. Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse

    Fentanyl is a fully synthetic opioid with analgesic and anesthetic properties. It has become a primary driver of the deadliest opioid crisis in the...

    Ying Han, Lu Cao, ... Lin Lu in Neuroscience Bulletin
    Article 15 May 2022
  8. Current analytical trends of abuse of tramadol and its forensic significance

    Introduction

    The utilization and misuse of prescription and controlled medications are expanding globally. However, the kind of substance abused may...

    Varsha Chauhan, Manisha, ... Priyanka Munjal in Toxicology and Environmental Health Sciences
    Article 22 June 2022
  9. The Role of 5-HT2B Receptor on Aggression and Drugs of Abuse

    Monoamines, particularly serotonin (5-hydroxytryptamine, 5-HT), have been extensively studied in the context of aggression. 5-HT is known to play a...
    Janitza L. Montalvo-Ortiz, Emil F. Coccaro in 5-HT2B Receptors
    Chapter 2021
  10. Intracranial Self-Stimulation: Using the Curve-Shift Paradigm to Assess the Abuse Potential of Drugs

    Intracranial self-stimulation (ICSS) is an operant conditioning procedure used to quantify the brain reward function. Thus, this procedure allows us...
    Ritchy Hodebourg in The Brain Reward System
    Protocol 2021
  11. Overdose and Alcohol Sensitive Immediate Release System (OASIS) for Deterring Accidental Overdose or Abuse of Drugs

    Death from an accidental or intentional overdose of sleeping tablets has increased exponentially in the USA. Furthermore, the simultaneous...

    Manali Patki, Siddhant Palekar, ... Ketankumar Patel in AAPS PharmSciTech
    Article 25 November 2020
  12. Cannabinoids Pharmacology, Abuse, and Addiction

    Cannabis has a long history of therapeutic use and misuse. Δ-9-tetrahydrocannabinol (THC) was identified as the principle psychoactive component of...
    Marilyn A. Huestis, Michael L. Smith in Neuroscience in the 21st Century
    Reference work entry 2022
  13. Effect of Manufacturing Process on the Retention of Abuse-Deterrent Properties of PEO-Matrix Tablets

    Polyethylene oxide (PEO) is a widely used polymer in the development of abuse-deterrent oral formulations. Different manufacturing processes...

    Leyla Rezaei, Saikishore Meruva, Maureen D. Donovan in AAPS PharmSciTech
    Article 27 December 2021
  14. Reinstatement of nicotine conditioned place preference in a transgenerational model of drug abuse vulnerability in psychosis: Impact of BDNF on the saliency of drug associations

    Rationale

    Psychotic disorders such as schizophrenia are often accompanied by high rates of cigarette smoking, reduced quit success, and high relapse...

    Loren D. Peeters, Liza J. Wills, ... Russell W. Brown in Psychopharmacology
    Article 09 May 2023
  15. Conditioned Place Preference Test for Assessing the Rewarding Effects of Drugs of Abuse

    The conditioned place preference (CPP) procedure is used for assessing the rewarding effects of drugs. This is demonstrated when a novel environment...
    Todd Hillhouse, Adam Prus in The Brain Reward System
    Protocol 2021
  16. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays—and how this matters for the harm potential of seized drugs

    Cultivation of industrial low-Δ 9 -tetrahydrocannabinol (Δ 9 -THC) hemp has created an oversupply of cannabidiol (CBD)-rich products. The fact that...

    Liesl K. Janssens, Katleen Van Uytfanghe, ... Christophe P. Stove in Archives of Toxicology
    Article 12 May 2024
  17. Implementing Nanovesicles for Boosting the Skin Permeation of Non-steroidal Anti-inflammatory Drugs

    The consumption of non-steroidal anti-inflammatory drugs (NSAIDs) have increased lately around the world, as they are considered essential and...

    Manar Adel Abdelbari, Ahmed Hassen Elshafeey, ... Shaimaa Mosallam in AAPS PharmSciTech
    Article Open access 28 September 2023
  18. New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development

    Since the landmark MTA (Multimodal Treatment of ADHD) trial unequivocally demonstrated the efficacy of methylphenidate, catecholaminergic drugs,...
    Chapter 2022
  19. Stimulant Drugs: Psychostimulants and Addiction

    Psychomotor stimulants belong to two major classes: direct and indirect sympathomimetics (such as cocaine and amphetamine) and nonsympathomimetics....
    Luigi Pulvirenti, Michel Le Moal, George F. Koob in Neuroscience in the 21st Century
    Reference work entry 2022
  20. Therapeutic and Toxic Concentrations of Drugs in Biological Matrices

    Therapeutic drug monitoring (TDM) describes the measurement of chemical parameters of drugs during clinical laboratory testing. TDM aids estimation...
    Seth Kwabena Amponsah, Yashwant V. Pathak in Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology
    Chapter 2022
Did you find what you were looking for? Share feedback.